Cargando…
Prospective Study of Withdrawal of Antiviral Therapy in Patients with Chronic Hepatitis B after Prolonged Virological Response
Nucleoside analogue (NA) therapy for chronic hepatitis B (CHB) is associated with improved clinical outcomes, but usually requires long‐term use. Whether treatment can be safely withdrawn and the factors associated with post‐withdrawal outcome are not well defined. To assess long‐term outcomes after...
Autores principales: | Gara, Naveen, Tana, Michele M., Kattapuram, Meera, Auh, Sungyoung, Sullivan, Lauren, Fryzek, Nancy, Walter, Mary, Umarova, Regina, Zhao, Xiongce, Cloherty, Gavin, Doo, Edward, Heller, Theo, Liang, T. Jake, Ghany, Marc G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557321/ https://www.ncbi.nlm.nih.gov/pubmed/34558806 http://dx.doi.org/10.1002/hep4.1761 |
Ejemplares similares
-
Three variants in the nicotinamide adenine dinucleotide phosphate oxidase complex are associated with HCV‐related liver damage
por: Page, Sandra J., et al.
Publicado: (2017) -
Paired unilateral scapular pits in a neonate
por: Kattapuram, Meera, et al.
Publicado: (2022) -
Withdrawing and Withholding Life-Prolonging Medical Treatment
por: Jessiman, Ian
Publicado: (2000) -
Antiviral Mechanisms: Perspectives in Virology, Volume IX
por: Darling, Tom
Publicado: (1976) -
Functional genomics in virology and antiviral drug discovery
por: DeFilippis, Victor, et al.
Publicado: (2003)